Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • THOMAPYRIN S® - Migraine Disorders
    Clinical Study Number 155.8
    Study Indication Migraine Disorders
    Product THOMAPYRIN S®
    Generic Name Paracetamol + Acetylsalicylic acid
    Lab Code
    Clinical Phase III
    Study Title

    A double-blind, randomized, placebo-controlled clinical trial to confirm the rationale of the ASA + paracetamol + caffeine combination compared with ASA + paracetamol as well as ASA, paracetamol and caffeine in headache patients

    Study Document
    Trial synopsis 155.8 english